MEG3 and brain cancer: Notably, MEG3 expression was significantly correlated with the prognosis of a total of nine types of cancers, including bladder cancer, brain cancer, breast cancer, head and neck cancer, blood cancer, colorectal cancer, eye cancer, lung cancer, and ovarian cancer.